Patents by Inventor Jiejia XU

Jiejia XU has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • GENETIC MARKERS FOR ENGRAFTMENT OF HUMAN CARDIAC VENTRICULAR PROGENITOR CELLS
    Publication number: 20230383345
    Abstract: The present invention provides genetic markers for identifying engraftable human cardiac ventricular progenitor cells. The engraftment markers of the invention include angiogenic markers and extracellular matrix markers. Human ventricular progenitor cells expressing these markers are capable of forming ventricular tissue in vivo that is vascularized and supported by an extracellular matrix. Methods of engrafting human cardiac ventricular progenitor cells by transplanting into a subject progenitor cells that express the engraftment markers are also provided.
    Type: Application
    Filed: August 14, 2023
    Publication date: November 30, 2023
    Inventors: Chuen Yan LEUNG, Jonathan CLARKE, Jiejia XU, Federica SANTORO, Makoto SAHARA, Kenneth CHIEN
  • Genetic markers for engraftment of human cardiac ventricular progenitor cells
    Patent number: 11725244
    Abstract: The present invention provides genetic markers for identifying engraftable human cardiac ventricular progenitor cells. The engraftment markers of the invention include angiogenic markers and extracellular matrix markers. Human ventricular progenitor cells expressing these markers are capable of forming ventricular tissue in vivo that is vascularized and supported by an extracellular matrix. Methods of engrafting human cardiac ventricular progenitor cells by transplanting into a subject progenitor cells that express the engraftment markers are also provided.
    Type: Grant
    Filed: March 3, 2020
    Date of Patent: August 15, 2023
    Assignee: Procella Therapeutics AB
    Inventors: Chuen Yan Leung, Jonathan Clarke, Jiejia Xu, Federica Santoro, Makoto Sahara, Kenneth R. Chien
  • GENETIC MARKERS FOR ENGRAFTMENT OF HUMAN CARDIAC VENTRICULAR PROGENITOR CELLS
    Publication number: 20200270685
    Abstract: The present invention provides genetic markers for identifying engraftable human cardiac ventricular progenitor cells. The engraftment markers of the invention include angiogenic markers and extracellular matrix markers. Human ventricular progenitor cells expressing these markers are capable of forming ventricular tissue in vivo that is vascularized and supported by an extracellular matrix. Methods of engrafting human cardiac ventricular progenitor cells by transplanting into a subject progenitor cells that express the engraftment markers are also provided.
    Type: Application
    Filed: March 3, 2020
    Publication date: August 27, 2020
    Inventors: Chuen Yan LEUNG, Jonathan CLARKE, Jiejia XU, Federica SANTORO, Makoto SAHARA, Kenneth R. CHIEN
  • Genetic markers for engraftment of human cardiac ventricular progenitor cells
    Patent number: 10612094
    Abstract: The present invention provides genetic markers for identifying engraftable human cardiac ventricular progenitor cells. The engraftment markers of the invention include angiogenic markers and extracellular matrix markers. Human ventricular progenitor cells expressing these markers are capable of forming ventricular tissue in vivo that is vascularized and supported by an extracellular matrix. Methods of engrafting human cardiac ventricular progenitor cells by transplanting into a subject progenitor cells that express the engraftment markers are also provided.
    Type: Grant
    Filed: February 15, 2017
    Date of Patent: April 7, 2020
    Assignee: Procella Therapeutics AB
    Inventors: Chuen Yan Leung, Jonathan Clarke, Jiejia Xu, Federica Santoro, Makoto Sahara, Kenneth R. Chien
  • GENETIC MARKERS FOR ENGRAFTMENT OF HUMAN CARDIAC VENTRICULAR PROGENITOR CELLS
    Publication number: 20170240964
    Abstract: The present invention provides genetic markers for identifying engraftable human cardiac ventricular progenitor cells. The engraftment markers of the invention include angiogenic markers and extracellular matrix markers. Human ventricular progenitor cells expressing these markers are capable of forming ventricular tissue in vivo that is vascularized and supported by an extracellular matrix. Methods of engrafting human cardiac ventricular progenitor cells by transplanting into a subject progenitor cells that express the engraftment markers are also provided.
    Type: Application
    Filed: February 15, 2017
    Publication date: August 24, 2017
    Inventors: Chuen Yan LEUNG, Jonathan CLARKE, Jiejia XU, Federica SANTORO, Makoto SAHARA, Kenneth R. CHIEN